Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 22.01.2025
Masterflex SE
Masterflex SE's Supervisory Board extends contracts of CEO Dr. Andreas Bastin and CFO Mark Becks
Continuation of successful collaboration
Continuity and reliability at the Management level to realize strategic goals
Gelsenkirchen, January 22, 2025 – The Supervisory Board of Masterflex SE (ISIN: DE0005492938) resolved to extend the contracts of th [ … ]
Wed, 22.01.2025
Evotec SE
Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry for Trade, Industry and Energy
Funding supports a novel collaboration to develop first-in-class therapeutic antibodies to treat asthma and idiopathic pulmonary fibrosis
Hamburg, Germany, 22 Janu [ … ]
Wed, 22.01.2025
SKAN AG
Ad hoc announcement pursuant to Art. 53 LR
SKAN announces preliminary key figures for the 2024 financial year
Allschwil, 22 January 2025 – The SKAN Group AG, world market leader for high-quality isolator systems for aseptic production processes in the (bio-) pharmaceutical industry, expects based on preliminary, not yet audited figures net sales [ … ]
Wed, 22.01.2025
Reinet Investments SCA
Reinet Investments S.C.A.’s wholly-owned subsidiary, Reinet Fund S.C.A., F.I.S., has today announced its net asset value as at 31 December 2024 as follows:
Quote
Reinet Fund S.C.A., F.I.S. (‘Reinet Fund’)
Net asset value per share as at 31 December 2024
As at 31 December 2024, the net asset value (‘NAV’) per share of Reinet Fund amounted to € 4 [ … ]
Wed, 22.01.2025
Relief Therapeutics Holding SA
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE® Rights ex-USSale of GOLIKE® Rights Outside the U.S. to Nutrisens
Relief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products
GENEVA (JAN. 22, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharm [ … ]
Wed, 22.01.2025
Schoeller-Bleckmann Oilfield Equipment AG
Preliminary results 2024: SBO with strong cash generation and solid results despite challenging market conditions
Ternitz/Vienna, 22 January 2025. Schoeller-Bleckmann Oilfield Equipment AG (SBO), listed in the leading ATX index of the Vienna Stock Exchange, today announced its preliminary results for the financial year 2024. Despite a challenging [ … ]
Wed, 22.01.2025
Cicor Technologies Ltd
Cicor Technologies Ltd
/ Key word(s): Statement
Statement on media report 22.01.2025 / 07:00 CET/CEST
Media Release
Bronschhofen, January 22, 2025 – Following a recent article in the French media, Cicor Group (SIX Swiss Exchange: CICN) indicates that it is in discussions with the company Éolane France and relevant governmental [ … ]
Tue, 21.01.2025
Schaeffler AG
Disclosure of an inside information according to Article 17 MAR of the Regulation (EU) No 596/2014
Schaeffler AG: Based on preliminary figures, EBIT margin before special items for fiscal year 2024 below group guidance
Herzogenaurach, 21 January 2025 – Schaeffler AG (DE000SHA0019) releases results for fiscal year 2024 based on preliminary and [ … ]
Tue, 21.01.2025
adidas AG
FOR IMMEDIATE RELEASEHerzogenaurach, January 21, 2025
adidas finishes successful year with better-than-expected fourth quarter results
adidas today announced preliminary results for the fourth quarter of 2024. In Q4, currency-neutral revenues increased 19%. In euro terms, the company’s revenues grew 24% to € 5,965 million (2023: € 4,812 million). [ … ]
Tue, 21.01.2025
Kudelski Group
Kudelski Group
/ Key word(s): Miscellaneous
Unlocking Efficiency and Reducing Loss: Kudelski IoT’s RecovR and KEYper Systems Team Up to Revolutionize Dealership Key Management in Automotive Retail
21.01.2025 / 17:50 CET/CEST
Phoenix, AZ, Cheseaux-sur-Lausanne, Switzerland, and Harrisburg, NC, January 21, 2025 — Kudels [ … ]